Synopsis of recent research by authors named "Eduards Sevostjanovs"
- Eduards Sevostjanovs' recent research primarily concentrates on the pharmacogenetics and pharmacokinetics of drugs related to tuberculosis treatment, particularly isoniazid and rifampicin, exploring their interactions with genetic polymorphisms and consequences such as hepatotoxicity in patients.
- His studies also investigate the metabolic effects of various substances, such as trimethylamine N-oxide (TMAO) and long-chain acylcarnitines, on cardiovascular health, providing insights into their roles in disease mechanisms including ischemia-reperfusion injury and cardiac dysfunction.
- Additionally, Sevostjanovs is exploring innovative methodologies to enhance the bioavailability of natural compounds like birch bark extracts, aiming to improve their therapeutic potential while addressing safety concerns around the increasing market of nootropics, particularly phenibut.
